Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.（CLDX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cldx · 股价预测 · 19 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 19 位华尔街分析师
Buy
19 位分析师
共识
评级分布
12 个月目标价
High
$54.00
Consensus
$51.00
+79.5% upside
Low
$48.00
Median: $51 · Last Close: $28.41
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$51.00
79.5% upside
High Target
$54
90.1%
Low Target
$48
69.0%
Current Price
$28.41
as of today
Based on analyst price targets, the CLDX stock price prediction for the next 12 months ranges from $48 to $54. The consensus CLDX price forecast of $51.00 implies 79.5% upside from the current price of $28.41.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $27.41 | ↓ 3.51% |
1-day model range: $27.29–$27.54. Peak: $27.54 (-3.51%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $21 | -27.6% |
| 2028 | $17 | -38.6% |
| 2029 | $16 | -43.7% |
| 2030 | $15 | -46.3% |
| 2031 | — | -47.6% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CLDX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-13 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-05-08 | Barclays | Maintains | Overweight→Overweight |
| 2026-04-20 | Barclays | Upgrade ↑ | Underweight→Overweight |
| 2026-03-02 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2026-02-26 | Stifel | Maintains | Buy→Buy |
| 2025-12-17 | Barclays | Maintains | Underweight→Underweight |
| 2025-11-11 | Barclays | Maintains | Underweight→Underweight |
| 2025-09-17 | Canaccord Genuity | Maintains | Buy→Buy |
| 2025-08-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-20 | Citigroup | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Celldex Therapeutics, Inc. (CLDX) stock. Of the recent 115 rating actions, 2 were upgrades and 13 were downgrades. 19 analysts currently cover CLDX.
分析师推荐趋势
CLDX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 2 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$2M
↓ 98.4% YoY
Revenue Next Year
$8M
↑ 245.2% YoY
EPS This Year
$-4.35
EPS Next Year
$-4.40
↑ 1.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast CLDX EPS of $-4.35 for the current fiscal year, based on estimates from 8 analysts. The CLDX revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CLDX 股价预测由两类独立数据源支撑：来自 19 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CLDX 的共识目标价为 $51.00（+79.5% 上行空间），分析师共识为 Buy。
CLDX 的短期预测（明日）为 $27.41（-3.51%）。 CLDX 对 2027 年的股价预测均值为 $21。 CLDX 对 2030 年的预测区间为 $15–$16。
Celldex Therapeutics, Inc. 在 NASDAQ 上市，代码 CLDX。CLDX 在 2027 年的整体展望偏积极，在覆盖分析师中约 89% 对应 Buy 共识。
常见问题
CLDX 预测 · 8 个问题根据 19 位华尔街分析师，CLDX 的 12 个月平均目标价为 $51.00，最高 $54.00、最低 $48.00。若有图表，中位目标价可在上方查看。相对当前价 $28.41，隐含约 +79.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.